Cognitive Training in Children with Attention-Deficit/Hyperactivity Disorder: A Randomised Controlled Trial

Professor Mark Bellgrove0 个研究点目标入组 55 人开始时间: 2020年9月28日最近更新: 2022年5月16日

试验速览

暂无简介。

•Is between the ages of 5 years and 8 years 11 months at the time of randomisation.
•- Has a primary DSM-IV or DSM-V diagnosis of ADHD as determined and confirmed by a trained clinician.
•- Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant’s behalf.
•- Whose parents/guardians agree to not initiate any other nonpharmacological therapy or intervention for the purpose of treating their child’s inattention for the 5-week intervention phase of the study.
•- Whose parents/guardians agree to keep a stable dose of ADHD medication (if the child is medicated) for at least 4 weeks prior to trial entry, and for the 5-week intervention phase of the study.

•- Is unable to comprehend or follow study instructions (English), including where uncorrected sensory or physical/motor impairments are present (as reported by the parent or observed by the investigator).
•- Has a history of major trauma
•- Has a diagnosed or borderline intellectual delay as defined as IQ<80 on the WISC-V/WPPSI-IV.
•- Has a known monogenic cause for their ADHD diagnosis.
•- Has comorbid diagnoses other than Autism Spectrum Disorder, with significant symptoms that, in the opinion of the investigator, may confound study data/assessments, i.e. oppositional defiant disorder, conduct disorder or severe mental health conditions (e.g. severe selective mutism). Participants with a learning disorder may participate provided the disorder does not impact their ability to take part in the trial.
•- Have not previously participated in a study of a cognitive training program
•- Do not have a sibling also enrolled in this study

发起方

Professor Mark Bellgrove